Medifast Q3 Loss Narrower Than Expected as Coach Productivity Rises

Medifast reported a Q3 adjusted loss of $0.19 per share, narrower than the $0.40 consensus loss, while revenue fell 19.4% year over year to $72 million but topped the $68 million estimate. Active earning coaches dropped 47.7% to about 10,200 amid client-acquisition challenges, including broader industry pressure from GLP-1 adoption, while revenue per coach rose 54.1% to $7,064. The company raised the low end of its 2026 revenue outlook to $280 million from $270 million, with a $280-$300 million range, and expects adjusted EBITDA of $10-$14 million; it remains debt-free with $172.5 million in cash, equivalents and investment securities.

Analysis

The key issue is whether higher revenue per coach reflects durable demand or a denominator effect from a much smaller, more productive surviving network. If client acquisition remains weak, further coach attrition could overwhelm productivity gains and keep revenue below the level needed to absorb the cost base. Gross-margin expansion and lower SG&A dollars are constructive, but SG&A still exceeds revenue-adjusted gross profit; near-flat adjusted EBITDA is not yet evidence of a self-funding recovery. Also, adjusted EBITDA excludes stock compensation and restructuring costs, so verify the bridge to reported cash generation.

Over the next 1–3 months, the Q4 guide’s unusually broad revenue range leaves meaningful execution uncertainty. Track active earning coaches, client additions/retention, revenue per coach, and whether EBITDA improvement is operational rather than accounting-driven. Over 6–18 months, GLP-1 adoption is a structural substitution risk, though coaching could prove complementary if Medifast can demonstrate incremental customer value. Cash and no debt reduce near-term balance-sheet risk, but do not resolve the business-model question.

Contrarian read: the recent share-price strength may over-credit productivity gains, while the bear case may underweight the potential for a leaner network and cost base to stabilize earnings. No clean peer hedge is established by the unrelated food names in the article.

Key Decisions for Investors

• Avoid chasing the rally; keep MED at most a catalyst watch until coach counts stabilize and revenue-per-coach gains translate into sustained positive operating cash flow.
• For a bearish, defined-risk expression, consider a small put spread only if options are liquid and premiums are reasonable; time it around the next operating update rather than assuming continued GLP-1-driven deterioration. Risk is a rapid coach stabilization or stronger-than-guided revenue/EBITDA.
• Falsify the cautious thesis if consecutive updates show improving client acquisition and active coach counts alongside sustained EBITDA progress; strengthen it if coach attrition accelerates, revenue falls toward the low end of guidance, or management cuts the outlook.
• Verify the adjusted-to-reported EBITDA and cash-flow reconciliation, coach cohort retention, and the source of per-coach growth before sizing a position; the headline productivity metric alone is insufficient.